Clinical Trial Update: MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a MUC1 vaccine to prevent lung cancer in current and former smokers at high risk; results were posted in 2023-04-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• MUC1 vaccine (Mucin-1 vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-19